RxDoctor Payments Data

Edward Johnson, MD

Family Medicine · Bossier City, LANPI 1285073890

Payments from drug & device makers

$1,704in general payments, 2019–2025

Across 64 payments — averaging $26.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$419
  • Lilly USA, LLC$376
  • Phathom Pharmaceuticals, Inc.$237
  • Novo Nordisk$184
  • AbbVie$142
  • Kowa Pharmaceuticals America, Inc.$125
  • plus $222 from 6 others

What the payments were for

  • Food & beverage$1,704100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,704 in reported general payments places this provider in the 65th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$20,377
Medicare patients
69
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide19$21,873
JardianceEmpagliflozin14$20,021
OzempicSemaglutide15$19,589
EliquisApixaban11$9,835
XareltoRivaroxaban11$7,957
Ezetimibe28$1,177
Albuterol Sulfate HfaAlbuterol Sulfate23$961
Atorvastatin Calcium121$895
Rosuvastatin Calcium47$824
Tamsulosin Hcl48$733
Levothyroxine Sodium69$618
Omeprazole39$578
Fenofibrate16$456
Lisinopril54$452
Potassium Chloride16$449

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$376$21,87319 claims
Novo NordiskOzempic$184$19,58915 claims
PfizerEliquis$113$9,83511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Bossier City

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →